Anlon Healthcare's Q4 FY 2025-26 Quarterly Results

Result Summary

• Anlon Healthcare Ltd reported a 42.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 3.9%.
• Its expenses for the quarter were up by 44.9% QoQ and 8.9% YoY.
• The net profit increased 115.0% QoQ and decreased 33.5% YoY.
• The earnings per share (EPS) of Anlon Healthcare Ltd stood at 2.33 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Anlon Healthcare Ltd is a company operating within the healthcare industry. While specific details about its main products or services are not provided, companies in this sector typically engage in the manufacture and distribution of pharmaceuticals, medical equipment, or healthcare-related services. Anlon Healthcare Ltd may be involved in one or more of these areas. Recent major developments relevant to the company are not available from the provided data. The healthcare industry is known for its continuous innovation and regulatory challenges, which may impact companies like Anlon Healthcare Ltd.

Revenue

In the fourth quarter of fiscal year 2026 (Q4FY26), Anlon Healthcare Ltd reported a total income of ₹50.90 crores. This represents a 42.3% increase from the third quarter of fiscal year 2026 (Q3FY26), where the total income was ₹35.78 crores. Compared to the same quarter in the previous fiscal year (Q4FY25), where the total income was ₹48.97 crores, there is a year-over-year increase of 3.9%. The growth in total income on both a quarterly and annual basis indicates a positive revenue trend for the company during this period.

Profitability

The company's profit before tax for Q4FY26 was ₹14.44 crores, a 36.1% increase from ₹10.61 crores in Q3FY26. However, this represents a 6.8% decrease from Q4FY25, where the profit before tax was ₹15.49 crores. Tax expenses for Q4FY26 were ₹3.37 crores, significantly lower than the ₹5.46 crores reported in Q3FY26, reflecting a 38.3% decrease. In Q4FY25, the company had a tax benefit of ₹1.16 crores. The profit after tax for Q4FY26 stood at ₹11.07 crores, showing a substantial 115.0% increase from the ₹5.15 crores recorded in Q3FY26, but a 33.5% decrease from the ₹16.65 crores in Q4FY25. Earnings per share also followed a similar pattern, with a value of ₹2.33 in Q4FY26, marking a 106.2% increase from Q3FY26 and a decline of 54.8% from Q4FY25.

Operating Metrics

Total expenses for Q4FY26 amounted to ₹36.46 crores, which is a 44.9% increase from the ₹25.16 crores in Q3FY26. When compared to Q4FY25, where total expenses were ₹33.48 crores, there is an 8.9% increase. The substantial rise in expenses on a quarterly basis aligns with the increase in total income, suggesting operational scaling or increased cost of operations. The company's earnings per share (EPS) in Q4FY26 was ₹2.33, up from ₹1.13 in Q3FY26, indicating a significant quarterly improvement. However, it shows a 54.8% decrease from the EPS of ₹5.15 in Q4FY25, reflecting a divergence in profitability trends on an annual basis.